Eli Lilly and Company

CONSULTOR TÉCNICO SR - IMUNOLOGIA

Brazil

Not SpecifiedCompensation
Junior (1 to 2 years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, HealthcareIndustries

Requirements

Candidates should possess a relevant higher education degree, such as a Bachelor's degree, and ideally a postgraduate degree in a related field; prior experience as a Technical Consultant in the immunology or rheumatology market, specifically within the context of accessing high-cost medications, is required; a strong understanding of the pharmaceutical landscape and access dynamics is essential; proficiency in English at the intermediate level is necessary; and familiarity with CRM systems like Veeva is desired; residing in Curitiba and being available for approximately 30% travel is also a requirement.

Responsibilities

The Consultant Técnico SR - Imunologia will provide technical, commercial, and medication access consulting services to clients, including physicians and infusion clinics, implementing marketing strategies to maximize product demand and improve patient quality of life; they will plan and implement technical and commercial strategies for high-cost medications, ensuring coverage of productivity metrics; engage with clients effectively, utilizing the VBS sales model and Lilly principles; maintain up-to-date medical knowledge, disease understanding, product information, and competitor analysis, continuously developing through self-learning and utilizing AI; integrate with various Lilly teams, including Marketing, Medical, Access, OCE, and Commercial; analyze and strategically manage accounts, achieving/exceeding demand targets; promote a culture of safety and diversity & inclusion; and ensure proper documentation within the Veeva CRM system.

Skills

MedicalConsulting
MarketAccess
CustomerInteraction
StrategicPlanning
SalesModelVBS
EventOrganization
HighCostMedication

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI